Dr. Mario Zanaty, MD

Dr. Zanaty practices at University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa.

Dr. Zanaty's NPI, 1316351075, was assigned on June 19, 2014. Dr. Zanaty holds Iowa license MD-51983.

Dr. Zanaty's primary practice is University of Iowa Health Care Medical Center, at 200 Hawkins Drive, Iowa City, IA 52242 in Johnson County. The practice phone is (319) 356-1616.

Dr. Zanaty's primary practice is University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa. Dr. Zanaty is also affiliated with University of Iowa Health Care Medical Center Downtown. The medical group on file is Scanlan Center for School Mental Health Clinic. Dmand AI also links Dr. Zanaty to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zanaty practices, 5 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Zanaty's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Zanaty is licensed in Iowa.

CMS data shows 486 Medicare services from Dr. Zanaty across 15 procedure codes in 2024, for 206 Medicare patients. Medicare paid $68,728 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 206 Medicare patients who saw Dr. Zanaty in 2024. The largest group is 65 to 74, with 102 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.48, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Zanaty's median patient age at 74, with 61% women.

In 2024, Dr. Zanaty wrote 111 Medicare Part D claims for 32 patients. 94% of them were for generic drugs. CMS names the drug for 70 of them, across 2 drugs with 11 or more claims each, at $236 in total drug cost. In 2018, CMS named 75 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Zanaty for performance year 2024, reported as part of a group. Dr. Zanaty accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zanaty as offering telehealth.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 134 papers to Dr. Zanaty, published from 2013 to 2025. 2019 was the busiest year, with 15. The most frequent topics are Intracranial Aneurysm, Aneurysm, Ruptured and Embolization, Therapeutic. Dr. Zanaty has published most often in World Neurosurg. Dr. Zanaty's most frequent co-authors are Pascal M. Jabbour, MD, Robert M. Starke, MD and David K. Kung, MD.

Dmand AI links Dr. Zanaty to 1 clinical trial. Conditions studied include Delirium and Confusion.

CMS Open Payments shows 121 general payments to Dr. Zanaty from 11 drug and device companies from 2016 to 2025. Grants make up the largest share, 51% of the total. Medtronic, Inc. paid the most, $52,556.